Navigation Links
AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
Date:6/16/2009

    GAI-122, an investigational injectable nano-emulsion formulated with
    AlphaRx's proprietary drug delivery technology, provides significant
    neuroprotection in animal behavioral models. Gaia BioPharma plans to
    initiate a clinical development program to further study GAI-122 for an
    acute and as yet, unmet neurological indication.

MARKHAM, ON, June 16 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTCBB: ALRX) and Gaia BioPharma Limited, a privately held, early stage biopharmaceutical company focused on hospital-based injectable therapeutics, are pleased to provide a progress report on GAI-122.

GAI-122 offers significant and direct neuroprotection in both in vitro and in vivo ischemic conditions. Experimental evidence suggests that the neuroprotective action of GAI-122 is related to its' active inhibition of apoptosis or cell death. GAI-122 shows potential as a major treatment innovation in the management of ischemic neurological disorders such as stroke and traumatic brain injury.

The proposed initial indication for GAI-122 is an acute neurological disorder affecting millions of patients undergoing cardiac and hip replacement surgery. It is estimated that the market potential for this unmet indication exceeds US$2 billion a year.

GAI-122 is in the final stage of formulation optimization, which is expected to be completed by the end of summer 2009, proceeding to clinical trial materials manufacturing thereafter. GAI-122 is protected by 4 US patent applications.

In October 2008, AlphaRx licensed GAI-122 to Gaia BioPharma. Under the terms of the amended agreement, AlphaRx is eligible to receive milestone payments of up to $50 million for the successful development and commercialization of GAI-122, as well as royalties on worldwide sales. In addition, Gaia BioPharma has assumed all development costs.

About AlphaRx Inc.

AlphaRx is a specialty pharmaceutical compa
'/>"/>

SOURCE AlphaRx Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AlphaRx Signs Cooperative Research and Development Agreement with US Army
2. AlphaRx Provides Corporate and Development Update
3. AlphaRxs Indaflex(TM) Continues its Clinical Development
4. AlphaRx CEO Accumulates More Company Shares
5. AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares
6. AlphaRx Announces Debt Conversion
7. AlphaRx To Present at 47th Annual ICAAC
8. PDL BioPharma Announces Record Date for October 1 Dividend Payment
9. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
10. SAFE-BioPharma Webinar Featuring ARX's Digital Signatures Combined with Microsoft SharePoint for Bio-Pharma industry
11. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 ... launch of two new product extensions, an accompanying ... headquarters, several novel marketing tools for their sales ... Vitamin Angels at their 5th annual national convention, ... room only crowd at the Hyatt Regency Orange ...
(Date:9/16/2014)... Recently, iFitDress.com, one of the most famous dress suppliers ... evening gown collection. According to the company’s sales manager, ... (up to 69% off) at present. Additionally, all the company’s ... am a frequent caller of your site. I like your ... feel quite happy. All items are of good quality. I ...
(Date:9/16/2014)... 2014 Today, Top10BestSEOHosting.com compares ... the USA and announces that HostMonster, Arvixe ... best Windows web hosting companies in the ... clients high quality WordPress hosting (including VPS ... , HostMonster provides outstanding customer support and ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Paradigm Physical ... offering a new therapeutic treatment for their patients. Dry ... to treat a variety of musculoskeletal problems. , In ... is inserted into the skin and muscle to create ... the needle, the needle helps to deactivate and release ...
(Date:9/16/2014)... September 16, 2014 Cliff Lake Dental Care ... Kristaleen is the newest dental hygienist to join Dr. Rauchwarter's ... to working with her and knows she will bring many ... , Kristaleen grew up in River Falls, WI. She ... College in 2003 and practiced dental assisting in the Twin ...
Breaking Medicine News(10 mins):Health News:New Products Announced at Jusuru International’s R2E14 National Convention 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 3Health News:New Products Announced at Jusuru International’s R2E14 National Convention 4Health News:iFitDress.com: One Shoulder Evening Gown Collection Unveiled Online 2Health News:Best Windows Web Hosting Suppliers Recommended By SEO Hosting Review Site Top10BestSEOHosting.com 2Health News:Paradigm Physical Therapy Introduces Dry Needling 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2
... Data Shows a Comprehensive Technology Infrastructure Improves Efficiency, ... March 10 Two Kaiser Permanente studies published ... a comprehensive electronic health record can increase consumer ... clinical quality and that connecting patients directly with ...
... More physician leaders are embracing technological advances, such as ... and unresponsive to their needs.Those are the results found ... Physician Executives (ACPE). The findings were published in the ... of medical management.ACPE conducted the same survey back in ...
... N.Y., March 10 NBTY, Inc. (NYSE: ... and marketer of nutritional supplements, today announced that it ... Chief Financial Officer of NBTY, at the B. Riley ... Wednesday, March 18, 2009.The presentation is scheduled to be ...
... Adjusted FIFO EBITDA Increases 4.3% to $26.1 Million, Excluding ... Full Year Adjusted FIFO EBITDA Increases 15% to $90.5 ... Net Cash Provided by Operating Activities Increases 130% to ... Million and Full Year Net Loss of $72.8 Million ...
... in corrective surgery operations from 2007 and 2008. ... is breast augmentations (breast enlargements), tummy tucks and ... largest cosmetic surgeons in the UK, can reveal ... cosmetic procedures, with the figure worryingly increasing to ...
... Holdings Ltd,("Obio"/ "the Company") announced the discovery of a ... influenza virus (including avian and human,influenza strains) such as ... TG21 has already commenced. , ... in USA and,China to conduct various researches, all of ...
Cached Medicine News:Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 2Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 3Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 4Health News:Survey Results: Health Care Technology Advances as Physician Frustration Grows 2Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 2Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 3Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 4Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 2Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 3Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 4Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 5Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 6Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 7Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 8Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 9Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 10Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 11Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 12Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 13Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 14Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 15Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 16Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 17Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 18Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 19Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 20Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 21Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 22Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 23Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 2Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 3Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 2Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 3
(Date:9/16/2014)... -- Endo International plc (NASDAQ: ENDP ) (TSX: ... acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. ... of $28.10 in a cash and stock transaction valued at ... 31% to Auxilium,s closing price on September 16, 2014 and ... shares for the previous 30 days.  Under the terms of ...
(Date:9/16/2014)... YORK , Sept. 16, 2014  This report analyzes ... Units, The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... , and Rest of World. Annual estimates and forecasts ... seven-year historic analysis is provided for these markets. Market data ...
(Date:9/16/2014)... , Sept. 16, 2014 Adaptive Biotechnologies, a ... (NGS) to profile the adaptive immune system, is pleased ... as Chief Commercial Officer (CCO). The addition of Brain ... key hires from leading global healthcare companies, including ... (General Counsel) from Genomic Health and Sean Nolan ...
Breaking Medicine Technology:Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 3Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 4Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 5Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 6Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 7Global Digital Radiography Industry 2Global Digital Radiography Industry 3Global Digital Radiography Industry 4Global Digital Radiography Industry 5Global Digital Radiography Industry 6Global Digital Radiography Industry 7Global Digital Radiography Industry 8Global Digital Radiography Industry 9Global Digital Radiography Industry 10Global Digital Radiography Industry 11Global Digital Radiography Industry 12Global Digital Radiography Industry 13Global Digital Radiography Industry 14Global Digital Radiography Industry 15Global Digital Radiography Industry 16Global Digital Radiography Industry 17Global Digital Radiography Industry 18Global Digital Radiography Industry 19Global Digital Radiography Industry 20Global Digital Radiography Industry 21Global Digital Radiography Industry 22Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 2Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 3
... intended for the immunochromatographic, qualitative determination ... Strip Gonorrhea is based on the ... determination of gonorrhea antigen in the ... system as an aid in the ...
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance....
The Smart Check Syphilis Device is a qualitative membrane device based immunoassay for the detection of TP (Treponema Pallidum) antibodies in whole blood/serum/plasma. For professional in vitro diagn...
Bio-Quant, Inc. OneStep hCG InstaTest is an immunochromatographic assay designed for qualitative determination of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy....
Medicine Products: